Skip to main content
Log in

Malignant melanoma in Europe: changes in mortality rates (1970-90) in European Community countries

  • Published:
Cancer Causes & Control Aims and scope Submit manuscript

Abstract

Reducing mortality, especially premature death, is a major goal of the fight against cancer. In this study, we have analyzed trends in malignant melanoma (MM) mortality in the European Community (EC) as a whole and for each country. The data (obtained from the World Health Organization data bank) have been analyzed for the period 1970-90, by age groups (20-44, 45-64, 65-74, 75+ years). Trends are presented as percentage change of mortality rate for each three-year period in comparison with the rate in the first one (1970-72). The mortality from MM in the EC as a whole increased for both genders (men, +89.2 percent; women, +72.6 percent), with statistically significant trends in all age classes. Northern countries experienced mortality changes about 30 to 50 percent less than the EC average increase. Greater changes were seen in southern European countries, in which recent standardized rates are near to those observed in northern European populations. Among Mediterranean people, the highest increase (more than fourfold) was observed in Spain. The significant increase found for the younger age class makes unlikely the risk of misclassification with other skin cancers. No future decrease in MM mortality in the EC is indicated from these data.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Muir CS, Nectoux J. Time trends: Malignant melanoma of skin. In: Magnus K, ed. Trend in Cancer Incidence. Causes and Practical Implications. Washington DC: Hemisphere Publishing, 1982: 365–85.

    Google Scholar 

  2. Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J, Powell J. Cancer Incidence in Five Continents, Vol VI. Lyon, France: International Agency for Research on Cancer, 1992; IARC Sci. Pub. No. 120: 952–3.

    Google Scholar 

  3. Lee JAH. Melanoma. In: Schottenfeld D, Fraumeni JF Jr, eds. Cancer Epidemiology and Prevention. Philadelphia, PA (USA): Saunders. 1982: 984–5.

    Google Scholar 

  4. Armstrong BK, Kricker A. Cutaneous melanoma. Trends in cancer incidence and mortality. Cancer Surveys 1994; 19: 219–40.

    Google Scholar 

  5. Thorn M, Sparen P, Bergstrom R, Adami HO. Trends in mortality rates from malignant melanoma in Sweden 1953–1987 and forecasts up to 2007. Br J Cancer 1992; 66: 563–7.

    Google Scholar 

  6. Cristofolini M, Piscioli F, Zumiani G. A program for de-tection of early cutaneous malignant melanoma in the province of Trento (Italy). Am J Dermatopathol 1984; 6(Suppl 1): 283–8.

    Google Scholar 

  7. Williams HC, Smith S, Du Vivier AWP. Evaluation of public education campaigns in cutaneous melanoma: The King's College Hospital experience. Br J Dermatol 1990; 123: 85–92.

    Google Scholar 

  8. Pehamberger H, Binder M, Knollamyer, Wolff K. Imme-diate effects of a public education campaign on prognostic features of melanoma. J Am Acad Dermatol 1993; 29: 106–8.

    Google Scholar 

  9. Rampen FHJ, Van Huystee BEWL, Kiemeney LALM. Practical considerations of melanoma/skin cancer screening clinics. Dermatology 1992; 184: 90–3.

    Google Scholar 

  10. MacKie RM, Osterlind A, Ruiter D, et al. Report on con-sensus meeting of the EORTC Melanoma Group on educational needs for primary and secondary prevention of melanoma in Europe. Eur J Cancer 1991; 27: 317–23.

    Google Scholar 

  11. MacKie RM, Hole D. Audit of public education campaign to encourage earlier detection of malignant melanoma. Br Med J 1992; 304: 1012–5.

    Google Scholar 

  12. World Health Organization. International Classification of Diseases, Ninth Revision. Geneva, Switzerland: WHO, 1997.

    Google Scholar 

  13. Doll R. Progress against cancer: an epidemiological assessment. Am J Epidemiol 1991; 134: 675–88.

    Google Scholar 

  14. Boyle P, Parkin DM. Statistical methods for registries. In: Jensen OM, Parkin DM, MacLennan R, Muir CS, Skeet RG, eds. Cancer Registration Principles and Methods. Lyon, France: International Agency for Research on Cancer, 1991; IARC Sci. Pub. No. 95: 126–58.

    Google Scholar 

  15. Franceschi S, Bidoli E, Prati S, Fascioli S, La Vecchia C. Mortality from skin melanoma in Italy and Friuli-Venezia Giulia Region, 1970–89. Tumor i 1994; 80: 251–6.

    Google Scholar 

  16. Van Der Esch EP, Muir CS, Nectoux J, et al. Temporal change in diagnostic criteria as a cause of the increase of malignant melanoma over time is unlikely. Int J Cancer 1991; 47: 483–90.

    Google Scholar 

  17. Scotto J, Pitcher H, Lee JAH. Indications of future decreasing trends in skin-melanoma among whites in the United States. Int J Cancer 1991; 49: 490–7.

    Google Scholar 

  18. Thorn M, Adami HO, Bergstrom R, et al. Trends in survival from malignant melanoma: remarkable improvement in 23 years. JNCI 1989; 81: 611–7.

    Google Scholar 

  19. MacKie RM, Hunter JAA, Aitchinson TC, et al. Malignant melanoma in Scotland 1979–89. Lancet 1992; 339: 971–5. D. Balzi et al 92 Cancer Causes and Control. Vol 8. 1997

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Balzi, D., Carli, P. & Geddes, M. Malignant melanoma in Europe: changes in mortality rates (1970-90) in European Community countries. Cancer Causes Control 8, 85–92 (1997). https://doi.org/10.1023/A:1018491323442

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1018491323442

Navigation